Why Tirzepatide Is Called ‘Ozempic on Steroids’ by Weight Loss Researchers
Tirzepatide (The “Twincretin”): How Dual-Action Agonists Are Changing Obesity Research Introduction: The Perfect Middle Ground In the rapidly evolving landscape of metabolic research, Tirzepatide (brand name Mounjaro, also known as LY3298176) has emerged as a landmark compound. As the first FDA-approved “Twincretin” — a dual GLP-1/GIP receptor agonist — it represents a significant evolution beyond single-agonist compounds like […]